Toll-like receptors, triggering receptor expressed on myeloid cells family members and receptor for advanced glycation end-products in allergic airway inflammation

References

Papers of special note have been highlighted as

• of interest

•• of considerable interest

• Agrawal DK, Shao Z. Pathogenesis of allergic airway inflammation. Curr Allergy Asthma Rep. 2010;10(1):39–48.
   PubMed Web of Science ®Google Scholar
• Hall S, Agrawal DK. Key mediators in the immunopathogenesis of allergic asthma. Int Immunopharmacol. 2014 Jun 13;23:316–329. pii: S1567-5769(14)00216-1. DOI:10.1016/j.intimp.2014.05.034.
   PubMed Web of Science ®Google Scholar
• Holgate ST. Innate and adaptive immune responses in asthma. Nat Med. 2012;18(5):673–683.
   PubMed Web of Science ®Google Scholar
• Masoli M, Fabian D, Holt S, Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 2004;59(5):469–478.
   PubMed Web of Science ®Google Scholar
• Hansel TT, Johnston SL, Openshaw PJ. Microbes and mucosal immune responses in asthma. Lancet. 2013;381(9869):861–873.
   PubMed Web of Science ®Google Scholar
• Kovach MA, Standiford TJ. Toll like receptors in diseases of the lung. Int Immunopharmacol. 2011;11(10):1399–1406.
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Kawai T, Toll-like receptor signaling pathways. Front Immunol. 2014;5:461.
   PubMed Web of Science ®Google Scholar

•Gives a comprehensive description of all toll-like receptors (TLRs), ligands and signaling pathways in the innate immune response.

• Lester SN, Li K. Toll-like receptors in antiviral innate immunity. J Mol Biol. 2014;426(6):1246–1264.
   PubMed Web of Science ®Google Scholar

•• Provides an in-depth review of TLRs, their ligands, cellular expression, signaling pathway and roles in antiviral immunity.

• Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009;21(1):38–46.
   PubMed Web of Science ®Google Scholar

•• Comprehensive analysis of triggering receptor expressed on myeloid cell (TREM) family members in inflammatory diseases and potential therapeutic targets for future research.

• Pelham CJ, Agrawal DK. Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(2):243–256.
   PubMed Web of Science ®Google Scholar
• Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5(4):331–342.
   PubMed Web of Science ®Google Scholar
• Nogueira-Machado JA, de Oliveira Volpe CM. HMGB-1 as a target for inflammation controlling. Recent Pat Endocr Metab Immune Drug Discov. 2012;6(3):201–209.
   PubMedGoogle Scholar
• Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637–650.
   PubMed Web of Science ®Google Scholar
• Chen K, Xiang Y, Yao X, et al. The active contribution of toll-like receptors to allergic airway inflammation. Int Immunopharmacol. 2011;11(10):1391–1398.
   PubMed Web of Science ®Google Scholar
• Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2010;42(4):506–518.
   PubMed Web of Science ®Google Scholar
• Ospelt C, Gay S. TLRs and chronic inflammation. Int J Biochem Cell Biol. 2010;42(4):495–505.
   PubMed Web of Science ®Google Scholar
• Thompson MR, Kaminski JJ, Kurt-Jones EA, et al. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3(6):920–940.
   PubMed Web of Science ®Google Scholar
• Jacquet A. Innate immune responses in house dust mite allergy. ISRN Allergy. 2013;2013:735031.
   PubMedGoogle Scholar
• Zuo L, Lucas K, Fortuna CA, et al. Molecular regulation of toll-like receptors in asthma and COPD. Front Physiol. 2015;6:312.
   PubMed Web of Science ®Google Scholar
• Trompette A, Divanovic S, Visintin A, et al. Allergenicity resulting from functional mimicry of a toll-like receptor complex protein. Nature. 2009;457(7229):585–588.
   PubMed Web of Science ®Google Scholar
• Phipps S, Lam CE, Kaiko GE, et al. Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses. Am J Respir Crit Care Med. 2009;179(10):883–893.
   PubMed Web of Science ®Google Scholar
• Saluja R, Delin I, Nilsson GP, et al. FcepsilonR1-mediated mast cell reactivity is amplified through prolonged toll-like receptor-ligand treatment. PLoS One. 2012;7(8):e43547.
   PubMed Web of Science ®Google Scholar
• Hammad H, Chieppa M, Perros F, et al. House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nat Med. 2009;15(4):410–416.
   PubMed Web of Science ®Google Scholar
• Ferreira DS, Annoni R, Silva LF, et al. Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma. Clin Exp Allergy. 2012;42(10):1459–1471.
   PubMed Web of Science ®Google Scholar
• Buckland KF, O’Connor E, Murray LA, et al. Toll like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice. Inflamm Res. 2008;57(8):379–387.
   PubMed Web of Science ®Google Scholar
• Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol. 2004;173(12):7548–7555.
   PubMed Web of Science ®Google Scholar
• Phipps S, Lam CE, Foster PS, et al. The contribution of toll-like receptors to the pathogenesis of asthma. Immunol Cell Biol. 2007;85(6):463–470.
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med. 2012;18(5):684–692.
   PubMed Web of Science ®Google Scholar
• Vanhoutte F, Paget C, Breuilh L, et al. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells. Immunol Lett. 2008;116(1):86–94.
   PubMed Web of Science ®Google Scholar
• Buchta CM, Bishop GA. Toll-like receptors and B cells: functions and mechanisms. Immunol Res. 2014;59(1–3):12–22.
   PubMed Web of Science ®Google Scholar
• Rawlings DJ, Schwartz MA, Jackson SW, et al. Integration of B cell responses through toll-like receptors and antigen receptors. Nat Rev Immunol. 2012;12(4):282–294.
   PubMed Web of Science ®Google Scholar
• Komiya A, Nagase H, Okugawa S, et al. Expression and function of toll-like receptors in human basophils. Int Arch Allergy Immunol. 2006;140(Suppl 1):23–27.
   PubMed Web of Science ®Google Scholar
• Suurmond J, Stoop JN, Rivellese F, et al. Activation of human basophils by combined toll-like receptor- and FcepsilonRI-triggering can promote Th2 skewing of naive T helper cells. Eur J Immunol. 2014;44(2):386–396.
   PubMed Web of Science ®Google Scholar
• Brar T, Nagaraj S, Mohapatra S. Microbes and asthma: the missing cellular and molecular links. Curr Opin Pulm Med. 2012;18(1):14–22.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Inoue H. Viral infections in asthma and COPD. Respir Investig. 2014;52(2):92–100.
   PubMedGoogle Scholar
• Zhou Y, Yang J, Deng H, et al. Respiratory syncytial virus infection modulates interleukin8 production in respiratory epithelial cells through a transcription factoractivator protein1 signaling pathway. Mol Med Rep. 2014;10(3):1443–1447.
   PubMed Web of Science ®Google Scholar
• Pritchard AL, White OJ, Burel JG, et al. Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS One. 2014;9(9):e106501.
   PubMed Web of Science ®Google Scholar
• Adner M, Starkhammar M, Georen SK, et al. Toll-like receptor (TLR) 7 decreases and TLR9 increases the airway responses in mice with established allergic inflammation. Eur J Pharmacol. 2013;718(1–3):544–551.
   PubMed Web of Science ®Google Scholar
• Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007;220:35–46.
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Baruah P, Manfredi AA, et al. HMGB1: guiding immunity from within. Trends Immunol. 2005;26(7):381–387.
   PubMed Web of Science ®Google Scholar
• Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2014;141(3):347–357.
   PubMed Web of Science ®Google Scholar
• Gonzalez I, Romero J, Rodriguez BL, et al. The immunobiology of the receptor of advanced glycation end-products: trends and challenges. Immunobiology. 2013;218(5):790–797.
   PubMed Web of Science ®Google Scholar
• Sukkar MB, Ullah MA, Gan WJ, et al. RAGE: a new frontier in chronic airways disease. Br J Pharmacol. 2012;167(6):1161–1176.
   PubMed Web of Science ®Google Scholar
• Kierdorf K, Fritz G. RAGE regulation and signaling in inflammation and beyond. J Leukoc Biol. 2013;94(1):55–68.
   PubMed Web of Science ®Google Scholar
• Rouhiainen A, Kuja-Panula J, Tumova S, et al. RAGE-mediated cell signaling. Methods Mol Biol. 2013;963:239–263.
   PubMedGoogle Scholar
• Shim EJ, Chun E, Lee HS, et al. The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma. Clin Exp Allergy. 2012;42(6):958–965.
   PubMed Web of Science ®Google Scholar
• Lee CC, Lai YT, Chang HT, et al. Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma. Biochem Pharmacol. 2013;86(7):940–949.
   PubMed Web of Science ®Google Scholar
• Liang Y, Hou C, Kong J, et al. HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2. Mol Cell Biochem. 2015;405(1–2):63–71.
   PubMed Web of Science ®Google Scholar
• Stenfeldt AL, Wenneras C. Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology. 2004;112(4):605–614.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Asai K, Fujimoto H, et al. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med. 2011;105(4):519–525.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Jiang YQ, Wang WX, et al. HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage. Hum Immunol. 2012;73(11):1171–1174.
   PubMed Web of Science ®Google Scholar
• Milutinovic PS, Alcorn JF, Englert JM, et al. The receptor for advanced glycation end products is a central mediator of asthma pathogenesis. Am J Pathol. 2012;181(4):1215–1225.
   PubMed Web of Science ®Google Scholar
• Ullah MA, Loh Z, Gan WJ, et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol. 2014 Aug;134(2):440–450. DOI:10.1016/j.jaci.2013.12.1035.
   PubMed Web of Science ®Google Scholar

•Most recent study highlighting the role of high-mobility group box -1 and receptor for advanced glycation end products (RAGE) in airway inflammation.

• Akirav EM, Henegariu O, Preston-Hurlburt P, et al. The receptor for advanced glycation end products (RAGE) affects T cell differentiation in OVA induced asthma. PLoS One. 2014;9(4):e95678.
   PubMed Web of Science ®Google Scholar
• Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42(1):45–52.
   PubMed Web of Science ®Google Scholar
• Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet. 2010;42(1):36–44.
   PubMed Web of Science ®Google Scholar
• Oczypok EA, Milutinovic PS, Alcorn JF, et al. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells. J Allergy Clin Immunol. 2015 Sep;136(3):747–756.e4. DOI:10.1016/j.jaci.2015.03.011.
   PubMed Web of Science ®Google Scholar
• Taniguchi A, Miyahara N, Waseda K, et al. Contrasting roles for the receptor for advanced glycation end-products on structural cells in allergic airway inflammation vs. airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol. 2015;309(8):L789–800.
   PubMed Web of Science ®Google Scholar
• Mahajan N, Dhawan V. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases. Int J Cardiol. 2013;168(3):1788–1794.
   PubMed Web of Science ®Google Scholar
• El-Seify MY, Fouda EM, Nabih ES. Serum level of soluble receptor for advanced glycation end products in asthmatic children and its correlation to severity and pulmonary functions. Clin Lab. 2014;60(6):957–962.
   PubMed Web of Science ®Google Scholar
• Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3(6):445–453.
   PubMed Web of Science ®Google Scholar
• Molloy EJ. Triggering receptor expressed on myeloid cells (TREM) family and the application of its antagonists. Recent Pat Antiinfect Drug Discov. 2009;4(1):51–56.
   PubMedGoogle Scholar
• Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology. 2008;213(9–10):701–713.
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A, Jurkowska M. Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12. Hum Immunol. 2013;74(6):730–737.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Oh SY, Cho YS, et al. Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation. Immunol Res. 2010;47(1–3):3–13.
   PubMed Web of Science ®Google Scholar
• Mittal Y, Pavlova Y, Garcia-Marcos M, et al. Src homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. J Biol Chem. 2011;286(37):32404–32415.
   PubMed Web of Science ®Google Scholar
• Peng Q, Malhotra S, Torchia JA, et al. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal. 2010;3(122):ra38.
   PubMed Web of Science ®Google Scholar
• Carow B, Rottenberg ME. SOCS3, a major regulator of infection and inflammation. Front Immunol. 2014;5:58.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Syed MA, Panchal D, et al. Triggering receptor expressed on myeloid cells 1 (TREM-1)-mediated Bcl-2 induction prolongs macrophage survival. J Biol Chem. 2014;289(21):15118–15129.
   PubMed Web of Science ®Google Scholar
• Arts RJ, Joosten LA, van der Meer JW, et al. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol. 2013;93(2):209–215.
   PubMed Web of Science ®Google Scholar

• Highlights shared interactions and signaling mechanisms of TLRs and TREM family members.

• Hommes TJ, Hoogendijk AJ, Dessing MC, et al. Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia. J Pathol. 2014;233(4):357–367.
   PubMed Web of Science ®Google Scholar
• Chung DH, Seaman WE, Daws MR. Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17. Eur J Immunol. 2002;32(1):59–66.
   PubMed Web of Science ®Google Scholar
• Klesney-Tait J, Colonna M. Uncovering the TREM-1-TLR connection. Am J Physiol Lung Cell Mol Physiol. 2007;293(6):L1374–6.
   PubMed Web of Science ®Google Scholar
• Syed MA, Joo M, Abbas Z, et al. Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. Exp Cell Res. 2010;316(19):3140–3149.
   PubMed Web of Science ®Google Scholar
• Buckland KF, Ramaprakash H, Murray LA, et al. Triggering receptor expressed on myeloid cells-1 (TREM-1) modulates immune responses to Aspergillus fumigatus during fungal asthma in mice. Immunol Invest. 2011;40(7–8):692–722.
   PubMed Web of Science ®Google Scholar
• Klesney-Tait J, Keck K, Li X, et al. Transepithelial migration of neutrophils into the lung requires TREM-1. J Clin Invest. 2013;123(1):138–149.
   PubMed Web of Science ®Google Scholar
• Wu K, Byers DE, Jin X, et al. TREM-2 promotes macrophage survival and lung disease after respiratory viral infection. J Exp Med. 2015;212(5):681–697.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Hernandez-Munain C, Cella M, et al. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med. 2001;194(8):1111–1122.
   PubMed Web of Science ®Google Scholar
• Ito H, Hamerman JA. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol. 2012;42(1):176–185.
   PubMed Web of Science ®Google Scholar
• Turnbull IR, Gilfillan S, Cella M, et al. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol. 2006;177(6):3520–3524.
   PubMed Web of Science ®Google Scholar
• Gao X, Dong Y, Liu Z, et al. Silencing of triggering receptor expressed on myeloid cells-2 enhances the inflammatory responses of alveolar macrophages to lipopolysaccharide. Mol Med Rep. 2013;7(3):921–926.
   PubMed Web of Science ®Google Scholar
• Sandquist M, Wong HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol. 2014;10(10):1349–1356.
   PubMed Web of Science ®Google Scholar
• Ten Oever J, Tromp M, Bleeker-Rovers CP, et al. Combination of biomarkers for the discrimination between bacterial and viral lower respiratory tract infections. J Infect. 2012;65(6):490–495.
   PubMed Web of Science ®Google Scholar
• Shi JX, Li JS, Hu R, et al. Diagnostic value of sTREM-1 in bronchoalveolar lavage fluid in ICU patients with bacterial lung infections: a bivariate meta-analysis. PLoS One. 2013;8(5):e65436.
   PubMed Web of Science ®Google Scholar
• Ye W, Hu Y, Zhang R, et al. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in lower respiratory tract infections: a meta-analysis. Respirology. 2014;19(4):501–507.
   PubMed Web of Science ®Google Scholar
• Phua J, Koay ES, Zhang D, et al. Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur Respir J. 2006;28(4):695–702.
   PubMed Web of Science ®Google Scholar
• Bucova M, Suchankova M, Dzurilla M, et al. Inflammatory marker sTREM-1 reflects the clinical stage and respiratory tract obstruction in allergic asthma bronchiale patients and correlates with number of neutrophils. Mediators Inflamm. 2012;2012:628754.
   PubMed Web of Science ®Google Scholar
• Ibrahim ZA, Armour CL, Phipps S, et al. RAGE and TLRs: relatives, friends or neighbours? Mol Immunol. 2013;56(4):739–744.
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Murata H, Yamamoto K, et al. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One. 2011;6(8):e23132.
   PubMed Web of Science ®Google Scholar

•Study indicating a functional interaction between RAGE and TLRs in inflammation and the immune response.

• Tadie JM, Bae HB, Jiang S, et al. HMGB1 promotes neutrophil extracellular trap formation through interactions with toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol. 2013;304(5):L342–9.
   PubMed Web of Science ®Google Scholar
• Deng Y, Yang Z, Gao Y, et al. Toll-like receptor 4 mediates acute lung injury induced by high mobility group box-1. PLoS One. 2013;8(5):e64375.
   PubMed Web of Science ®Google Scholar
• Zheng H, Heiderscheidt CA, Joo M, et al. MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands. Eur J Immunol. 2010;40(1):162–171.
   PubMed Web of Science ®Google Scholar
• Habibzay M, Saldana JI, Goulding J, et al. Altered regulation of toll-like receptor responses impairs antibacterial immunity in the allergic lung. Mucosal Immunol. 2012;5(5):524–534.
   PubMed Web of Science ®Google Scholar
• Molad Y, Pokroy-Shapira E, Carmon V. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding. Innate Immun. 2013;19(6):623–630.
   PubMed Web of Science ®Google Scholar
• Bezemer GF, Sagar S, van Bergenhenegouwen J, et al. Dual role of toll-like receptors in asthma and chronic obstructive pulmonary disease. Pharmacol Rev. 2012;64(2):337–358.
   PubMed Web of Science ®Google Scholar
• Hatchwell L, Collison A, Girkin J, et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax. 2015;70(9):854–861. doi:10.1136/thoraxjnl-2014-205465.
   PubMed Web of Science ®Google Scholar
• Drake MG, Kaufman EH, Fryer AD, et al. The therapeutic potential of Toll-like receptor 7 stimulation in asthma. Inflamm Allergy Drug Targets. 2012;11(6):484–491.
   PubMedGoogle Scholar
• Nawijn MC, Motta AC, Gras R, et al. TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice. PLoS One. 2013;8(2):e55307.
   PubMed Web of Science ®Google Scholar
• Gibot S, Alauzet C, Massin F, et al. Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis. 2006;194(7):975–983.
   PubMed Web of Science ®Google Scholar
• Derive M, Massin F, Gibot S. Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases. Self Nonself. 2010;1(3):225–230.
   PubMedGoogle Scholar